295 related articles for article (PubMed ID: 24950005)
21. Potential use of RNA interference in cancer therapy.
Phalon C; Rao DD; Nemunaitis J
Expert Rev Mol Med; 2010 Aug; 12():e26. PubMed ID: 20716384
[TBL] [Abstract][Full Text] [Related]
22. RNA interference therapy for glioblastoma.
Guo D; Wang B; Han F; Lei T
Expert Opin Biol Ther; 2010 Jun; 10(6):927-36. PubMed ID: 20415602
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
24. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
25. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
Kozielski KL; Rui Y; Green JJ
Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
[TBL] [Abstract][Full Text] [Related]
26. Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.
Gindy ME; Leone AM; Cunningham JJ
Expert Opin Drug Deliv; 2012 Feb; 9(2):171-82. PubMed ID: 22251440
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional Oligoaminoamides for the Receptor-Specific Delivery of Therapeutic RNA.
Weber J; Lächelt U; Wagner E
Methods Mol Biol; 2015; 1324():369-86. PubMed ID: 26202283
[TBL] [Abstract][Full Text] [Related]
28. Recent progress in non-viral nucleic acids delivery.
Salem AK; Patil SD; Burgess DJ
Int J Pharm; 2012 May; 427(1):1-2. PubMed ID: 22143087
[No Abstract] [Full Text] [Related]
29. Innovative nanotechnologies for the delivery of oligonucleotides and siRNA.
Toub N; Malvy C; Fattal E; Couvreur P
Biomed Pharmacother; 2006 Nov; 60(9):607-20. PubMed ID: 16952435
[TBL] [Abstract][Full Text] [Related]
30. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
31. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
32. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
[TBL] [Abstract][Full Text] [Related]
33. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
Plane G
IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
[TBL] [Abstract][Full Text] [Related]
34. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
Singh SK; Hajeri PB
Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
36. The potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery.
Shorter SA; Gollings AS; Gorringe-Pattrick MAM; Coakley JE; Dyer PDR; Richardson SCW
Expert Opin Drug Deliv; 2017 May; 14(5):685-696. PubMed ID: 27548881
[TBL] [Abstract][Full Text] [Related]
37. Cell-penetrating peptides for the delivery of nucleic acids.
Lehto T; Kurrikoff K; Langel Ü
Expert Opin Drug Deliv; 2012 Jul; 9(7):823-36. PubMed ID: 22594635
[TBL] [Abstract][Full Text] [Related]
38. MATra - Magnet Assisted Transfection: combining nanotechnology and magnetic forces to improve intracellular delivery of nucleic acids.
Bertram J
Curr Pharm Biotechnol; 2006 Aug; 7(4):277-85. PubMed ID: 16918404
[TBL] [Abstract][Full Text] [Related]
39. [Research progress on the development of the strategies for siRNAs delivery in vivo].
Tang D; Mao A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
[TBL] [Abstract][Full Text] [Related]
40. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
